We’re proud to announce that we’ve been selected to pitch our solution at Europe’s leading platform for HealthTech innovation and investment — the HealthTech Investor Summit, taking place 8–10 December 2025 in Utrecht. For three days, we’ll be joining innovators, investors, and industry experts to exchange ideas, explore partnerships, and unlock new funding opportunities. Read more

A big thank-you to PRAXI Network and Brookstreet Equity Partners LLP for the ConnectingTheDots initiative and for highlighting the strength of Greek innovation. At PhosPrint, we’re bringing Laser BioPrinting and regenerative medicine closer to the patient — providing research teams and tools for targeted tissue therapies. We’re proud of our progress and excited for the next steps in London on 14 November 2025. Many thanks to the organizers, judges, and community for their tru

We are pleased to announce that Ioanna Zergioti, CEO of PhosPrint P.C., has been elected Vice President of the Photonics21 Executive Board during the annual meeting held on May 15–16 in Brussels. ​ PhosPrint is an active member of the Board of Stakeholders of Photonics21, the European Technology Platform that brings together over 3,800 leading photonics companies, research organizations, and innovation players across Europe. ​ Ioanna Zergioti’s appointment highlights her sign